Laure Farnault

1.1k total citations
38 papers, 549 citations indexed

About

Laure Farnault is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Laure Farnault has authored 38 papers receiving a total of 549 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Hematology, 9 papers in Genetics and 9 papers in Oncology. Recurrent topics in Laure Farnault's work include Acute Myeloid Leukemia Research (12 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Acute Lymphoblastic Leukemia research (6 papers). Laure Farnault is often cited by papers focused on Acute Myeloid Leukemia Research (12 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Acute Lymphoblastic Leukemia research (6 papers). Laure Farnault collaborates with scholars based in France, Switzerland and Spain. Laure Farnault's co-authors include Régis Costello, Jennifer Cautela, Franck Thuny, Stéphane Éderhy, Ariel Cohen, Joachim Alexandre, Charles Dolladille, Geoffroy Venton, Fabrice Barlési and Carole Sanchez and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Laure Farnault

32 papers receiving 547 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laure Farnault France 11 185 165 135 121 119 38 549
Athanasios Galanopoulos Greece 10 159 0.9× 163 1.0× 211 1.6× 88 0.7× 115 1.0× 40 492
Q.H. Le France 8 170 0.9× 202 1.2× 313 2.3× 34 0.3× 59 0.5× 16 613
Sophie Rigaudeau France 11 165 0.9× 114 0.7× 238 1.8× 26 0.2× 125 1.1× 22 558
Niels Frost Andersen Denmark 17 294 1.6× 63 0.4× 371 2.7× 105 0.9× 425 3.6× 42 756
Sim Leng Tien Singapore 12 78 0.4× 54 0.3× 120 0.9× 29 0.2× 112 0.9× 41 448
Leon Su United States 11 117 0.6× 76 0.5× 240 1.8× 243 2.0× 140 1.2× 29 738
Monika Długosz‐Danecka Poland 13 226 1.2× 93 0.6× 34 0.3× 68 0.6× 49 0.4× 44 485
Maciej Kaźmierczak Poland 13 90 0.5× 30 0.2× 194 1.4× 63 0.5× 161 1.4× 41 475
Rachele Amodeo Italy 9 95 0.5× 49 0.3× 32 0.2× 115 1.0× 77 0.6× 16 490
Isabelle Genvresse Germany 12 157 0.8× 21 0.1× 169 1.3× 76 0.6× 107 0.9× 27 472

Countries citing papers authored by Laure Farnault

Since Specialization
Citations

This map shows the geographic impact of Laure Farnault's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laure Farnault with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laure Farnault more than expected).

Fields of papers citing papers by Laure Farnault

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laure Farnault. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laure Farnault. The network helps show where Laure Farnault may publish in the future.

Co-authorship network of co-authors of Laure Farnault

This figure shows the co-authorship network connecting the top 25 collaborators of Laure Farnault. A scholar is included among the top collaborators of Laure Farnault based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laure Farnault. Laure Farnault is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Farnault, Laure, et al.. (2025). Body mass index affects imatinib exposure: Real‐world evidence from TDM with adaptive dosing. Fundamental and Clinical Pharmacology. 39(1). e13049–e13049. 2 indexed citations
2.
Farnault, Laure, et al.. (2024). Relationship of body mass index and plasma imatinib levels in CML patients and mitigation of clinical impact using PK-guided dosing strategy.. Journal of Clinical Oncology. 42(16_suppl). e18522–e18522.
3.
Boucraut, José, Aude‐Marie Grapperon, Laure Farnault, et al.. (2023). Clinical, biological, electrophysiological and therapeutic profile of patients with anti-MAG neuropathy according to MYD88L265P and CXCR4 mutations and underlying haemopathy. Journal of Neurology. 271(3). 1320–1330. 1 indexed citations
4.
Venton, Geoffroy, Laure Farnault, Yaël Berda‐Haddad, et al.. (2023). Determination of 5-azacitidine in human plasma by LC–MS/MS: application to pharmacokinetics pilot study in MDS/AML patients. Cancer Chemotherapy and Pharmacology. 91(3). 231–238. 2 indexed citations
5.
Ciccolini, Joseph, et al.. (2023). Cytidine deaminase status as a marker of response to azacytidine treatment in MDS and AML patients. British Journal of Haematology. 203(4). 625–636. 1 indexed citations
6.
Farnault, Laure, Thomas Robert, Sylvain Choquet, et al.. (2022). Successful treatment with adapted high dose methotrexate in a hemodialysis patient with primary central nervous system lymphoma: 100 mg/m2 seems sufficient. Nefrología (English Edition). 42(2). 130–134. 1 indexed citations
7.
Gabert, Jean, Anne‐Laure Couderc, Laure Farnault, et al.. (2022). Impact of Molecular Biology in Diagnosis, Prognosis, and Therapeutic Management of BCR::ABL1-Negative Myeloproliferative Neoplasm. Cells. 12(1). 105–105. 4 indexed citations
8.
Cauchois, Raphaël, Marie Koubi, Pierre‐André Jarrot, et al.. (2021). Clinical characteristics and outcomes of patients with haematologic malignancies and COVID-19 suggest that prolonged SARS-CoV-2 carriage is an important issue. Annals of Hematology. 100(11). 2799–2803. 13 indexed citations
9.
Ciccolini, Joseph, Yaël Berda‐Haddad, Élise Kaspi, et al.. (2021). Pharmacokinetics and pharmacogenetics of liposomal cytarabine in AML patients treated with CPX-351. Journal of Controlled Release. 338. 244–252. 5 indexed citations
10.
Venton, Geoffroy, et al.. (2021). The contribution of single-cell analysis of acute leukemia in the therapeutic strategy. Biomarker Research. 9(1). 50–50. 7 indexed citations
11.
Couderc, Anne‐Laure, P. Villani, Laure Farnault, et al.. (2020). High Serum Vitamin B12 Levels Associated with C-Reactive Protein in Older Patients with Cancer. The Oncologist. 25(12). e1980–e1989. 5 indexed citations
12.
Venton, Geoffroy, Laure Farnault, Bertrand Pourroy, et al.. (2020). Pharmacokinetics/pharmacodynamics of liposomal cytarabine (VYXEOS) in AML patients: Influence of cytidine deaminase genetic polymorphisms.. Journal of Clinical Oncology. 38(15_suppl). e19517–e19517. 3 indexed citations
13.
Venton, Geoffroy, Pierre Suchon, Cédric Mercier, et al.. (2019). Efficacy and safety of autologous stem cell transplantation after induction therapy with lenalidomide, bortezomib, and dexamethasone. European Journal Of Haematology. 103(4). 385–392.
14.
Venton, Geoffroy, Franck Thuny, Laure Farnault, et al.. (2019). Pulmonary hypertension in patients with myeloproliferative neoplasms: A large cohort of 183 patients. European Journal of Internal Medicine. 68. 71–75. 17 indexed citations
15.
Solas, Caroline, Geoffroy Venton, Laure Farnault, et al.. (2019). Simultaneous determination of cytosine arabinoside and its metabolite uracil arabinoside in human plasma by LC-MS/MS: Application to pharmacokinetics-pharmacogenetics pilot study in AML patients. Journal of Chromatography B. 1126-1127. 121770–121770. 11 indexed citations
16.
Farnault, Laure, Zofia Hélias‐Rodzewicz, Geoffroy Venton, et al.. (2019). Response to trametinib of histiocytosis with an activating PTPN11 mutation. Leukemia & lymphoma. 61(1). 194–197.
17.
Venton, Geoffroy, et al.. (2016). Micafungin as primary antifungal prophylaxis in patients presenting with acute myeloid leukemia. Médecine et Maladies Infectieuses. 46(4). 226–229. 6 indexed citations
18.
Venton, Geoffroy, Mileidys Pérez‐Alea, Guy Fournet, et al.. (2016). Aldehyde dehydrogenases inhibition eradicates leukemia stem cells while sparing normal progenitors. Blood Cancer Journal. 6(9). e469–e469. 54 indexed citations
19.
Venton, Geoffroy, Béatrice Loriod, Nicolas Fernandez, et al.. (2016). Natural killer cells in acute myeloid leukemia patients: from phenotype to transcriptomic analysis. Immunologic Research. 64(5-6). 1225–1236. 18 indexed citations
20.
Farnault, Laure, et al.. (2010). Allo-immunisation fœto-maternelle rhésus anti-RH3, 4 (anti-E et anti-c) : à propos d’un cas. Archives de Pédiatrie. 18(2). 176–182. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Athanasios Galanopoulos Breakdown of academic impact, for papers by Q.H. Le Breakdown of academic impact, for papers by Sophie Rigaudeau Breakdown of academic impact, for papers by Niels Frost Andersen Breakdown of academic impact, for papers by Sim Leng Tien Breakdown of academic impact, for papers by Leon Su Breakdown of academic impact, for papers by Monika Długosz‐Danecka Breakdown of academic impact, for papers by Maciej Kaźmierczak Breakdown of academic impact, for papers by Rachele Amodeo Breakdown of academic impact, for papers by Isabelle Genvresse
Rankless by CCL
2026